You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Response criteria

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1

Not yet recruiting
  • Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
  • Ivosidenib 500mg
  • Placebo
  • (no location specified)
Nov 7, 2023

Post-transplant Lymphoproliferative Disorder Trial in Saint Louis (Polatuzumab vedotin, Rituximab, CHP)

Not yet recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Polatuzumab vedotin
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 9, 2023

Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)

Not yet recruiting
  • Advanced Mucosal Melanoma
  • Envafolimab combined with recombinant human endostatin and first-line chemotherapy
  • (no location specified)
Sep 15, 2023

Advanced Solid Tumors Trial in United States (REGN7075, cemiplimab)

Recruiting
  • Advanced Solid Tumors
  • San Francisco, California
  • +9 more
Jan 30, 2023

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

NSCLC Trial in Chongqing (Aumonertinib 165mg orally once daily and intrathecal chemo with pemetrexed)

Recruiting
  • Non-small Cell Lung Cancer
  • Aumonertinib 165mg orally once daily and intrathecal chemotherapy with pemetrexed
  • Chongqing, China
    chongqing University Three Gorges Hospital
Apr 11, 2023

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma Trial in Japan (epcoritamab

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • epcoritamab (monotherapy)
  • +5 more
  • Chuo Ku, Japan
  • +19 more
Nov 22, 2022

Autoimmune Encephalitis Trial in Paris (FDG PET)

Not yet recruiting
  • Autoimmune Encephalitis
  • FDG PET
  • Paris, France
    Hospital Pitie Salpetriere
Oct 16, 2023

Efficacy of Lenvatinib in Differentiated Thyroid Cancer

Recruiting
  • Differentiated Thyroid Cancer
  • Gender
  • Rome, Italy
    Regina Elena National Cancer Institute
Mar 16, 2023

Follow up After TACE by Elastography and Color Doppler.

Not yet recruiting
  • Hepatocellular Carcinoma
  • US
  • (no location specified)
Oct 2, 2023

Nasopharyngeal Carcinoma, Recurrent or Metastatic Trial in Beijing (KL-A167, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent or Metastatic
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 23, 2022

The ImmunoXXL Study

Recruiting
  • Hepatocellular Carcinoma
  • Liver Transplantation
  • Milano, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
May 25, 2023

Melanoma Trial in Worldwide (Talimogene Laherparepvec, Pembrolizumab, Placebo)

Terminated
Has Results
  • Melanoma
  • Talimogene Laherparepvec
  • +2 more
  • Birmingham, Alabama
  • +160 more
Nov 10, 2022

Uveal Melanoma Trial in Spain (Tislelizumab, Sitravatinib Malate)

Not yet recruiting
  • Uveal Melanoma
  • Málaga, Andalucia, Spain
  • +5 more
Sep 13, 2022

Recurrent Glioblastoma Trial in Los Angeles (Activated T cells)

Not yet recruiting
  • Recurrent Glioblastoma
  • Activated T cells
  • Los Angeles, California
    Cedars-Sinai Medical Center
Apr 21, 2022

Follicular Lymphoma Trial in France (Rituximab IV, Rituximab SC)

Completed
  • Follicular Lymphoma
  • Rituximab IV
  • Rituximab SC
  • Aix En Provence, France
  • +49 more
Jan 9, 2023

Uveal Melanoma Trial in Minneapolis (PAC-1, Entrectinib)

Active, not recruiting
  • Uveal Melanoma
  • Minneapolis, Minnesota
    HealthPartners Institute Regions Cancer Care Center
Nov 15, 2022

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Prostatic Neoplasms
  • (no location specified)
Nov 21, 2023

Myeloma Multiple Trial (Off Drug Surveillance)

Not yet recruiting
  • Myeloma Multiple
  • Off Drug Surveillance
  • (no location specified)
Jun 27, 2023

Patients With Soft Tissue Sarcoma According to CHOI Criteria

Completed
  • Soft Tissue Sarcoma
    • Bordeaux, France
    • +5 more
    May 13, 2019

    Unresectable or Metastatic Melanoma Trial in Australia, United States (Ipilimumab, NY-ESO-1 Protein Vaccine, NY-ESO-1 OLP4

    Terminated
    Has Results
    • Unresectable or Metastatic Melanoma
    • Ipilimumab
    • +3 more
    • New York, New York
    • +4 more
    Oct 3, 2022

    Pancreatic Cancer, Ultrasonography, First-line Chemo Trial in Beijing (Contrast-enhanced ultrasound(CEUS))

    Recruiting
    • Pancreatic Cancer
    • +2 more
    • Contrast-enhanced ultrasound(CEUS)
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Feb 6, 2023

    Angina, Stable, CHF, COPD Trial in Pittsfield, Springfield (Stepped Care)

    Recruiting
    • Angina, Stable
    • +2 more
    • Stepped Care
    • Pittsfield, Massachusetts
    • +1 more
    Oct 19, 2022

    Metastatic Castration-Resistant Prostate Cancer Trial in China, United States (ZEN003694, Enzalutamide)

    Recruiting
    • Metastatic Castration-Resistant Prostate Cancer
    • San Francisco, California
    • +21 more
    Aug 18, 2022

    COLPAC (RaDiCo Cohort) (RaDiCo-COLPAC)

    Active, not recruiting
    • Low Phospholipid Associated Cholelithiasis
      • Aix-en-Provence, France
      • +20 more
      Jul 18, 2023